(TRNS) Transcat - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8935291075
TRNS: Calibration, Laboratory, Instruments, Services, Test, Measurement
Transcat Inc, a company listed on the NASDAQ under the ticker TRNS, is a provider of calibration and laboratory instrument services, operating across the United States, Canada, and international markets. The company's operations are divided into two primary segments: Service and Distribution. The Service segment is focused on delivering a range of services including calibration, repair, inspection, and preventative maintenance, all of which are critical for ensuring the accuracy and reliability of instruments used in various industries. Additionally, this segment offers consulting services and analytical qualification, further emphasizing the company's commitment to comprehensive support. A key component of the Service segment is CalTrak, a proprietary system designed to manage the workflow of calibration service centers and customer assets efficiently. Furthermore, the Compliance, Control and Cost portal provides customers with a secure, web-based platform for asset management and the storage of calibration and service records, enhancing transparency and accessibility.
The Distribution segment of Transcat Inc is dedicated to the sale and rental of test, measurement, and control instruments, catering to the diverse needs of customers in terms of test and measurement instrumentation. This segment also offers a variety of value-added services, including the calibration and certification of purchased equipment, equipment rental options, the sale of used equipment, and equipment kitting services. These services are marketed and sold through multiple channels, including the company's website, digital and print advertising, proactive outbound sales efforts, and an inbound call center. This multi-channel approach enables Transcat Inc to reach a broad customer base and provide convenient access to its products and services. The company's customer portfolio spans highly regulated industries, with a significant focus on life sciences, including pharmaceutical, biotechnology, and medical device companies, as well as aerospace and defense, industrial manufacturing, energy and utilities, and other sectors where precision and compliance are paramount.
With its incorporation dating back to 1964, Transcat Inc has established itself as a veteran player in the industry, with its headquarters located in Rochester, New York. The company's website, https://www.transcat.com, serves as a central hub for information and services, offering insights into its operations, products, and commitment to quality and customer satisfaction. As a publicly traded company, Transcat Inc's common stock is listed under the ISIN US8935291075, and it is classified under the GICS Sub Industry as a Trading Company & Distributor, reflecting its role in the supply chain of critical instruments and services for various industries.
Additional Sources for TRNS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TRNS Stock Overview
Market Cap in USD | 985m |
Sector | Industrials |
Industry | Industrial Distribution |
GiC Sub-Industry | Trading Companies & Distributors |
IPO / Inception | 1990-03-27 |
TRNS Stock Ratings
Growth 5y | 78.1% |
Fundamental | 35.9% |
Dividend | - |
Rel. Strength Industry | -85.1 |
Analysts | 4.4/5 |
Fair Price Momentum | 113.76 USD |
Fair Price DCF | 47.13 USD |
TRNS Dividends
No Dividends PaidTRNS Growth Ratios
Growth Correlation 3m | -23.1% |
Growth Correlation 12m | -3% |
Growth Correlation 5y | 93.7% |
CAGR 5y | 26.38% |
CAGR/Mean DD 5y | 1.93 |
Sharpe Ratio 12m | 0.21 |
Alpha | -15.46 |
Beta | 0.68 |
Volatility | 45.38% |
Current Volume | 114.2k |
Average Volume 20d | 75.3k |
As of January 22, 2025, the stock is trading at USD 104.58 with a total of 114,186 shares traded.
Over the past week, the price has changed by -1.13%, over one month by -0.57%, over three months by -21.19% and over the past year by +3.85%.
Partly, yes. Based on ValueRay Fundamental Analyses, Transcat (NASDAQ:TRNS) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 35.91 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRNS as of January 2025 is 113.76. This means that TRNS is currently overvalued and has a potential downside of 8.78%.
Transcat has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy TRNS.
- Strong Buy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, TRNS Transcat will be worth about 125.2 in January 2026. The stock is currently trading at 104.58. This means that the stock has a potential upside of +19.67%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 121.2 | 15.9% |
Analysts Target Price | 121.2 | 15.9% |
ValueRay Target Price | 125.2 | 19.7% |